NSTEMI ACS management


Prof Dr Saumitra Ray, Kolkata    03 December 2017

All NSTEMI ACS are not the same. Early risk stratification should guide initial management. In high or moderate risk patients early invasive management is useful. Low risk patients should be treated conservatively with close watch. DAPT for at least one year is the dictum unless very high bleeding risk. High dose statin is useful. Total revascularization should be the aim as opposed to STEMI.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.